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Infection of genital epithelial cells by the closely related sexually transmitted pathogens Chlamydia tracho-
matis serovars E and L2 results in different clinical disease manifestations. Following entry into target host
cells, individual vesicles containing chlamydiae fuse with one another to form one large inclusion. At the
cellular level, the only obvious difference between these serovars is the time until inclusion maturation, which
is 48 h for the invasive serovar L2 and 72 h for serovar E. To begin to define the intracellular events of these
pathogens, the effect of cytoskeletal disruption on early endosome fusion and inclusion development in
epithelial (HEC-1B) and fibroblast (McCoy) cells was analyzed by fluorescence microscopy. Disruption of
microfilaments with cytochalasin D markedly reduced serovar E, but not serovar L2, infection of both cell lines.
Conversely, microfilament as well as microtubule disruption, with colchicine or nocodazole, had no effect on
serovar E inclusion development but resulted in the formation of multiple serovar L2 inclusions per cell during
early and mid-development. Later in serovar L2 inclusion development (>36 h postinfection), vesicles con-
taining chlamydiae fused to form one large inclusion in the absence of an intact cytoskeleton. These results
imply that (i) C. trachomatis serovar E may utilize a different pathway for uptake and development from serovar
L2; (ii) these differences are consistent in both epithelial cells and fibroblasts; and (iii) the cytoskeleton plays
a unique role in the infection of host cells by these two genital pathogens.
Chlamydia trachomatis strains consist of serological variants
responsible primarily for eye disease and genital tract infec-
tions. The strains are all antigenically related but are distin-
guished by their immunologic reactions into various serovars.
Serovars A, B, Ba, and C cause hyperendemic blinding tra-
choma. The lymphogranuloma venereum (LGV) biovar (sero-
vars L1, L2, and L3) and the C. trachomatis biovar (serovars D
to K) are responsible for sexually transmitted infections. The
former is epidemic in parts of Asia, Africa, and South America,
whereas the latter is responsible for epidemic disease in the
United States and Europe, causing an estimated 4.5 million
infections annually (63). These obligate intracellular bacteria
infect the columnar epithelial cells of the genital mucosae,
causing an initial urethritis or cervicitis. In the absence of
antibiotic exposure, the C. trachomatis serovars, which are lu-
minal pathogens, spread canalicularly in an ascending fashion
to infect the epididymus or the endometrium and fallopian
tubes. In contrast, the LGV serovars are more invasive patho-
gens which spread through the submucosa to infect the ingui-
nal lymph nodes and may eventually reach the bloodstream.
At the cellular level, chlamydial pathogenesis begins with the
entry of infectious elementary bodies (EB) into the genital
epithelia. Once inside the eukaryotic host cell, EB remain
within membrane-bound vesicles which fuse with one another
early after entry to form one large vesicle, even under high
multiplicities of infection (4), but presumably evade fusion
with lysosomes (12–14, 64). The metabolically inert EB then
transform into metabolically active, noninfectious forms, called
reticulate bodies (RB). The RB divide by binary fission to fill
the vesicle containing chlamydiae. Once this vesicle becomes
large enough to detect with a light microscope, 16 to 24 h after
infection, it is then called an inclusion (50). Late in the devel-
opmental cycle, which is approximately 48 h for LGV and 72 h
for serovar E, an unknown signal triggers the condensation of
RB into EB. The infectious EB progeny are then released from
the host cell to infect neighboring cells and perpetuate the
infectious cycle.
Since chlamydiae are ubiquitous pathogens which infect a
variety of cells in culture, many investigators have used in vitro
model systems to examine the entry process. From these stud-
ies, evidence exists for the entry of C. trachomatis serovar E
into host cells by receptor-mediated endocytosis via clathrin-
coated pits (53, 62), a mechanism which is believed to be
microfilament (MF) independent. The requirement of a func-
tional actin network for endocytosis in the yeast Saccharomyces
cerevisiae however, has recently been discovered (27) and
found to be similar to the endocytosis seen at the apical mem-
brane in polarized mammalian cells. Other investigations sug-
gest that the actin cytoskeleton is required for all apical endo-
cytosis, whether it be by adsorptive or fluid-phase pinocytosis
(17), and that proteins in the coat of clathrin-coated vesicles
bind to actin filaments (26). Hence, endocytosis may involve
MF.
Ward and colleagues first demonstrated a need for MF (59)
and calcium (60) in chlamydial uptake. These investigators
showed that the uptake of C. trachomatis serovar L2 into HeLa
cells was suppressed 50% by the disruption of MF. This finding
was subsequently confirmed by Reynolds and Pearce (46) for
the uptake of serovar L2 into McCoy cells and added to the
growing hypothesis that chlamydiae utilize both phagocytic
(MF-dependent) and pinocytic (MF-independent) mecha-
nisms for entry. Recently, a study showed data which suggest
that bacteria utilize different invasion mechanisms depending
upon the presence of different surface receptors on various cell
types (37). Ridderhof and Barnes (47) demonstrated that MF
permitted the fusion of serovar E-containing vesicles with se-
rovar F-containing vesicles in multiply infected HeLa cells.
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While the studies of Majeed (32, 33) colocalized clathrin and
F-actin to the site of entry of serovars E and L2 into HeLa and
McCoy cells, these investigators seemed to believe that the
roles of intracellular calcium and MF were more important for
the aggregation of vesicles containing chalmydiae following
chlamydial entry. More recently, the calcium-dependent fusion
of vesicles containing chlamydiae has been shown to involve
annexins (31). The identification of proteins in the chlamydial
inclusion membrane may soon shed light on the mechanisms
that regulate vesicle aggregation and fusion during chlamydial
infections.
Currently, the role of the microtubule (MT) lattice in the
primary stages of genital chlamydial infection is also unclear.
MT are ubiquitous elements of the cytoskeleton and are in-
volved in many cellular functions, including (i) the mainte-
nance of cell shape (51) and cellular organelle organization
(25); (ii) vesicular trafficking (18, 20), including endosomes and
lysosomes (35) as well as Golgi vesicles (57); and the fusion of
apical to basolateral late endosomes (1, 6); (iii) mitochondrial
transport (29); (iv) apical protein transport and apical secre-
tion of certain lysosomal proteins (11, 42); and (v) basolateral-
to-apical transcytosis of the polymeric immunoglobulin recep-
tor (23) as well as basolateral laminin secretion (5). Several
investigations have also found that endocytosis and receptor
recycling are slowed down in the presence of MT-disrupting
drugs (24, 30, 38). Only a few studies have examined the effects
of MT disruption on chlamydial infection.
The MT-disrupting drugs vincristine and vinblastine did not
appear to affect serovar L2 attachment to HeLa cells but did
have an effect on internalization (59) as well as coalescence
and localization of vesicles containing chlamydiae in the pe-
rinuclear region (36). Since vesicles containing EB previously
exposed to UV irradiation could correctly localize to the nu-
clear hof, while vesicles containing heat-treated EB could not,
McBride and Wilde (36) speculated that a protein in the chla-
mydial inclusion membrane may interact with the host cell
cytoskeleton. From these studies and the fact that, to date, no
drug disrupting receptor-mediated endocytosis, MT, or MF
completely abolishes chlamydial infectivity, it seems most likely
that chlamydiae utilize several different routes of uptake in
order to invade a wide variety of eukaryotic cells. Regardless of
the entry mechanism, once inside the host cell, the multiple C.
trachomatis-containing membrane-bound vesicles are known
to fuse with one another to form one large, mature inclusion
(4, 8).
The roles of MF and MT in C. trachomatis genital tract
infections are still unclear but appear to be important in chla-
mydial vesicle fusion, migration, and inclusion development.
We hypothesize that MT function in the transport of the ma-
ture inclusion to the appropriate membrane, apical or basolat-
eral, for escape from the host cell. Since serovars E and L2
differ in their in vivo sequelae, efficiency of infection, length of
developmental cycle, and possibly the host cell receptor used
for entry, we focused on comparing their use of the host cell
cytoskeleton. Previous investigations concerning the role of the
cytoskeleton in chlamydial infections quantitated the amount
of binding or entry of radiolabeled EB to drug-exposed fibro-
blasts without examining the morphological changes in inclu-
sion formation which occurred upon cytoskeletal damage in
infected cells. The purpose of these studies was to examine the
aggregation and formation of chlamydial inclusions within fi-
broblasts and epithelial cells devoid of polymerized MF or MT
as a result of exposure to cytoskeleton-disrupting drugs.
MATERIALS AND METHODS
Cells and medium. The human endometrial epithelial cell line HEC-1B (HTB-
113; American Type Culture Collection, Rockville, Md.) and the mouse fibro-
blast cell line McCoy (ATCC CRL 1696) were used in these experiments. Eu-
karyotic cells were grown on 12-mm-diameter glass coverslips coated with poly-
L-lysine or in a polarized fashion on collagen-coated polycarbonate filters as
described previously (63) in Dulbecco’s minimal essential medium (DMEM-H)
containing Earle’s salts, 584 mg of L-glutamine per liter, 4,500 mg of glucose per
liter, and 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
and supplemented with 10% (vol/vol) fetal calf serum (HyClone).
Chlamydial strains and growth conditions. The chlamydial strains used were
C. trachomatis E/UW-5/CX (serovar E), a human urogenital isolate, and C.
trachomatis biovar LGV L2/434/Bu (serovar L2), obtained from C. C. Kuo and
S. P. Wang, University of Washington, Seattle. Chlamydial stocks were harvested
from McCoy cells grown on Cytodex 3 beads (Sigma) as described previously
(55). Eukaryotic cells were inoculated at 358C with purified EB stock, diluted in
0.02 M phosphate buffer containing 0.2 M sucrose and 0.73 mg of glutamine per
ml (2SPG), to yield a 90 to 100% infection of the monolayer. To ensure an even
infection of the monolayer, a small inoculum volume (50 ml) was used and the
tissue culture plates were tapped by hand at 15-min intervals during the 2-h
adsorption period. DMEM-H was then added, and cells were incubated in an
atmosphere of 5% CO2 at 358C.
Disruption of MF. Cytochalasin D (CD; 0.5 mg/ml in dimethyl sulfoxide
[DMSO]; Sigma) was diluted in DMEM-H to the desired concentration. Host
cells, grown to subconfluency on glass coverslips, were pretreated with 0.5, 1.0,
2.5, or 4.0 mg of CD per ml for 1 h at 358C before infection with chlamydiae. CD
was maintained within the medium during all subsequent incubations.
Disruption of MT. Host cell MT were depolymerized with 10 mM colchicine
(Sigma) in DMEM-H for 30 min at 48C and then for 3.5 h at 358C by the
procedure of Gilbert et al. (16). Cells were then washed with fresh DMEM-H
and 2SPG before inoculation with chlamydiae. Colchicine was not present in the
medium during or after chlamydial infection.
MT disruption was alternatively obtained with exposure to 33 mM nocodazole
(Sigma) for 30 min at 48C followed by a 2.5-h incubation at 358C before chla-
mydial inoculation. Nocodazole was maintained at 33 mM during the 2-h chla-
mydial adsorption and within the medium for subsequent incubation times.
Fluorescence staining and examination. Following cold methanol fixation,
chlamydial inclusions were stained with fluorescein isothiocyanate (FITC)-la-
beled monoclonal antibodies specific to the major outer membrane protein of C.
trachomatis, which results in yellow-green inclusions and Evans blue-counter-
stained red eukaryotic cells (Syva; Syva Microtrak, San Jose, Calif.).
MF were visualized by staining F-actin with BODIPY fluorescein (FL)-phal-
lacidin (Molecular Probes). Eukaryotic cells on coverslips were fixed for 10 min
with 3.7% formaldehyde in phosphate-buffered saline (PBS), washed, and dehy-
drated in acetone. Coverslips were air dried and incubated in FL-phallacidin for
20 min at 258C. Samples were washed and mounted in a 1:1 solution of PBS-
glycerol.
To stain for MT, methanol-fixed eukaryotic cells were incubated for 1 h at
378C with a primary mouse monoclonal anti-b-tubulin antibody (Sigma), diluted
1:200 in PBS containing 1% immunoglobulin G-free bovine serum albumin
(BSA; Sigma). Primary antibody was detected with a FITC-conjugated goat
anti-mouse secondary antibody (Sigma), diluted 1:200 in PBS. Samples were
dried and mounted in polyvinyl alcohol.
BODIPY FL C5-DMB-ceramide (Molecular Probes) was used to stain the
Golgi apparatus. This dye associates with cholesterol in the membrane bilayer of
this organelle (41) and fluoresces green in dilute amounts or red when concen-
trated. Eukaryotic cells grown on coverslips were washed in serum-free
DMEM-H and incubated for 15 min at 358C with 2.5 mM DMB-ceramide in
serum-free medium containing 0.34 mg of fatty acid-free BSA (DF-BSA; Sigma)
per ml. Coverslips were then washed and incubated in serum-free medium
containing 0.34 mg of DF-BSA per ml for 40 min at 358C.
Eukaryotic cell viability was assessed by incubating the cells in a mixture of 0.1
mg of FL-diacetate (Sigma) per ml and 0.1 mg of propidium iodide (Sigma) per
ml in PBS. Live cells take up FL-diacetate, while the red propidium iodide enters
only dead cells. The cells were incubated at 358C for 10 min, washed in PBS,
mounted, and examined immediately. All fluorescent stains were examined by
epifluorescence microscopy at a magnification of 3400 with a Zeiss Axiovert
inverted microscope (Carl Zeiss Inc., Thornwood, N.Y.) equipped with a mer-
cury bulb and fluorescence filter sets. Confocal fluorescence microscopy of po-
larized, Syva-stained HEC-1B cells infected with serovar L2 was performed with
a Zeiss LSM 10 microscope.
Determination of chlamydial infectivity. To determine the effects of CD on C.
trachomatis inclusion development, we examined the infection of host monolay-
ers grown on glass coverslips from three separate experiments. Each time point
and concentration of CD examined represents an average of cells counted from
four replicate coverslips. Approximately 400 Syva-stained cells from four sepa-
rate microscopic fields were examined per coverslip. In the early stages of
infection (4 to 16 h postinfection [p.i.]), the number of vesicles containing
chlamydiae per cell was counted and the average was determined. At mid- to late
stages of infection (24 to 48 h p.i.), the number of inclusions per cell and the
percent infectivity were determined. Percent infectivity was determined as the
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number of infected cells divided by the total number of cells times 100. Values
were adjusted so that untreated control cells were 100% infected.
Transmission electron microscopy. Serovar L2-infected HEC-1B cells grown
on polycarbonate filters were prefixed for 1 h at 258C with 2% glutaraldehyde–
0.01% paraformaldehyde in 0.1 M sodium cacodylate buffer. Polycarbonate
filters supporting polarized HEC-1B cells infected with serovar L2 were pro-
cessed for embedding in Epon-Araldite resin for examination by contrast trans-
mission electron microscopy as described previously (62). Thin sections were cut
on a Reichert Ultracut S microtome (Leica) and poststained with 5% aqueous
uranyl acetate and 6% lead citrate before viewing on a Zeiss 900 microscope
operating at 50 kV.
RESULTS
MF disruption. Uninfected McCoy cells were first exposed
to various concentrations of the MF-disrupting agent CD and
then stained with FL-phallacidin to determine if any polymer-
ized actin remained. After a 1-h incubation in 0.5 mg of CD per
ml, a few stress fibers were visible, but no filamentous actin was
visible in McCoy cells exposed to 1.0, 2.5, and 4.0 mg of CD per
ml. HEC-1B cells, incubated with all CD concentrations spec-
ified above and stained with FL-phallacidin, did not contain
any visible actin filaments. The viability of HEC-1B and Mc-
Coy cells was examined with fluorescent dyes after 24- and 48-h
incubations in the presence of 4 mg of CD per ml. Approxi-
mately 10% of the HEC-1B cells were not viable after 24 h and
20% were not viable after 48 h, whereas only 5% of the McCoy
cells were dead at 24 and 48 h in the presence of 4 mg of CD
per ml.
When subconfluent monolayers of HEC-1B andMcCoy cells
were exposed to the range of CD concentrations (0.5, 1.0, 2.5,
and 4.0 mg/ml) for 1 h and then infected with serovar E EB, a
reduction in the number of serovar E-containing vesicles
within the infected cells was seen at 4 and 8 h p.i. compared
with mock (DMSO)-treated and untreated cells. This concen-
tration-dependent reduction in the percent infection of both
HEC-1B and McCoy cells was maintained through 24 (Fig. 1),
32, and 42 (Fig. 2) h p.i. The serovar E inclusions that did form,
however, had a morphology similar to those in DMSO-treated
and untreated cells (Fig. 2), in which all of the serovar E-con-
taining vesicles fused to form one inclusion. Even at the high-
est concentration of CD, the infectivity of host cells by serovar
E was not completely abolished.
In contrast, serovar L2-infected monolayers of HEC-1B or
McCoy cells exposed to the various concentrations of CD for 1
h did not show a reduction in the number of L2-containing
vesicles within the cells at 4 or 8 h p.i. compared with DMSO-
and untreated cells. Similarly, there was no reduction in the
percentage of CD-exposed HEC-1B or McCoy cells that were
infected by serovar L2 at 24 or 32 h p.i. (Fig. 3) compared with
DMSO-treated and untreated cells.
Serovar L2-containing vesicles normally aggregate and fuse
rapidly after entering the cytoplasm of the host cell and by 8 to
12 h p.i., depending on the number of EB that continue to
enter the cell during this time, have fused to form one inclusion
surrounded by a single vesicular membrane. In both cell types
exposed to CD, serovar L2-containing vesicles did not aggre-
gate within the host cell at 4 or 8 h p.i. and remained as
separate multiple vesicles within the host cell at 24 and 32 h p.i.
(Fig. 3). Figure 3 shows the inclusion morphology of the single
serovar L2 inclusion within each DMSO-exposed cell com-
pared with the multiple inclusions seen at 24 and 32 h p.i. in
CD-exposed cells. At 24 h p.i., the average number of L2-
containing vesicles per cell was two to four times higher than
that in untreated cells (see Fig. 5). By 42 h p.i., however,
serovar L2 inclusions did fuse with one another in the presence
of 4 mg of CD per ml (Fig. 3). Thus, CD was an effective
disrupting agent of MF in epithelial cells and fibroblasts and
discriminated between serovar E and L2 infection and inclu-
sion development in both eukaryotic cell types.
MT disruption. The effectiveness of MT disruption by col-
chicine or nocodazole in epithelial cells and fibroblasts was
determined by fluorescent staining of b-tubulin. The MT in
HEC-1B and McCoy cells remained depolymerized for up to
48 h after colchicine was removed from the medium. At 74 h
after colchicine removal, MT started to repolymerize in
HEC-1B cells. In cells exposed to nocodazole, MT started to
repolymerize 4 h after the drug was removed. All HEC-1B and
McCoy cells remained viable after 24 and 48 h of exposure to
colchicine or nocodazole, although they were rounded and
became multinucleate. FL-phallacidin staining of HEC-1B
cells exposed to colchicine did not reveal any MF damage as
assessed by epifluorescence microscopy.
The effect of MT disruption on the development of C. tra-
chomatis was determined by examining inclusion morphology
in drug-exposed cells. Colchicine and nocodazole did not affect
the ability of C. trachomatis serovar E to infect and form
mature inclusions in both HEC-1B and McCoy cells. At 24, 36
(Fig. 4), and up to 70 h p.i., the morphology of serovar E
inclusions appeared the same as those in DMSO-exposed cells.
In contrast, a detectable decrease in serovar L2-containing
vesicle aggregation, manifested as multiple well-spread small
inclusions, was identified at 4, 8, and 16 h p.i. in nocodazole- or
FIG. 1. Disruption of MF with CD reduces C. trachomatis serovar E infection
of epithelial cells and fibroblasts. HEC-1B (A) or McCoy (B) cells were preex-
posed to DMSO (1:125) or CD at various concentrations for 1 h before infection
with serovar E. Inclusions were stained with Syva at 24 h p.i., and the percent
infectivity was determined. Values are means 6 standard errors of the means
from three experiments.
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colchicine-exposed HEC-1B and McCoy cells. These serovar
L2 inclusions remained separated at 24 (Fig. 6) and 36 h p.i.
and had the same morphology as those in CD-exposed cells. By
44 h p.i., which is late in the serovar L2 developmental cycle,
inclusion fusion had occurred in the presence of colchicine or
nocodazole and single serovar L2 inclusions developed in both
HEC-1B and McCoy cells (Fig. 6).
Transmission electron microscopic examination of thin sec-
tions of polarized, colchicine-exposed HEC-1B cells confirmed
the existence of multiple serovar L2-containing vesicles per cell
FIG. 2. MF disruption in HEC-1B and McCoy cells with CD does not affect C. trachomatis serovar E inclusion formation but does decrease infectivity. Chlamydial
inclusions were stained with Syva after methanol fixation. (A and B) Serovar E inclusions 42 h p.i. in HEC-1B cells; (C and D) serovar E in McCoy cells 42 h p.i. (A
and C) Cells exposed to DMSO at 1:125; (B and D) cells exposed to CD at 4 mg/ml.
FIG. 3. MF disruption with CD in HEC-1B and McCoy cells leads to the formation of multiple C. trachomatis serovar L2 inclusions per cell but does not affect
infectivity. Serovar L2 inclusions were methanol fixed and stained with Syva in HEC-1B (A and B) or McCoy (C to H) cells exposed to DMSO at 1:125 (A, C, E, and
G) or CD at 4 mg/ml (B, D, F, and H). (A to D) 24 h p.i.; (E and F) 32 h p.i.; (G and H) 42 h p.i.
FIG. 4. MT disruption does not affect the development of C. trachomatis serovar E inclusions or the amount of infection of HEC-1B or McCoy cells. Serovar
E-infected McCoy (A and B) or HEC-1B (C and D) cells at 24 (A and B) or 36 (C and D) h p.i. Host cells were untreated (A and C) or treated with 10 mM colchicine
(B) or 33 mM nocodazole (D) for 4 h before inoculation with serovar E.
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(Fig. 7). The electron micrographs of 24-h-p.i. serovar L2 in-
clusions within colchicine-exposed HEC-1B cells showed EB
and RB that appeared the same as those in untreated cells.
Confocal fluorescence microscopy of infected colchicine-ex-
posed HEC-1B cells, grown polarized on polycarbonate filters,
also revealed multiple serovar L2-containing vesicles at 24 h
p.i. (data not shown).
When nocodazole, a reversible disrupter of MT, was re-
moved from the medium of HEC-1B cells at 2 or 4 h after
serovar L2 infection, inclusion fusion proceeded normally.
However, if nocodazole was removed at 8 or 12 h after infec-
tion, multiple L2 inclusions per cell were seen. When nocoda-
zole was added to the medium as late as 12 h p.i., multiple
serovar L2 inclusions were still observed in HEC-1B cells.
These data show that MT disruption discriminates between
serovar E and L2 inclusion development but does not affect the
ability of chlamydia to infect host cells.
Chlamydial progeny viability. To determine the infectivity
titer of the progeny, C. trachomatis serovar L2 was grown
within cytoskeleton-disrupted HEC-1B cells, isolated at 42 h
p.i., and inoculated onto untreated HEC-1B cells. These un-
treated HEC-1B cells were examined 24 h later to determine
the percentage which developed mature inclusions. Serovar
L2, isolated from HEC-1B cells exposed to 4 mg of CD per ml,
infected 50% of the untreated host monolayer, compared with
100% infection by serovar L2 isolated from untreated control
cells. In contrast, serovar L2 isolated from colchicine-exposed
HEC-1B cells infected 100% of the untreated HEC-1B mono-
layer, as did the progeny from untreated HEC-1B cells. Thus,
C. trachomatis serovar L2 is capable of producing infectious
progeny within cells lacking an intact cytoskeleton.
Localization of the Golgi. Because vesicles departing from
the Golgi are known to traffic along MT (57), we were con-
cerned that the depolymerization of MT within host cells may
inhibit the flow of vital nutrients from the Golgi to the growing
inclusion and thus result in the observed decrease in serovar L2
inclusion fusion. To detect the fusion of Golgi vesicles with the
chlamydial inclusion membrane, the sphingolipids of the trans-
Golgi apparatus in infected HEC-1B cells were localized with
C5-DMB-ceramide. At 24 h after serovar L2 infection of
HEC-1B or McCoy cells, the Golgi label was identified as
punctate dots surrounding the chlamydial inclusion (Fig. 8).
Host cells exposed to colchicine exhibited a more diffuse stain-
ing pattern, but the ceramide was still seen ringing the serovar
L2 inclusions. The same staining pattern occurred when sero-
var E was examined within HEC-1B cells at 35 h p.i. in the
presence or absence of colchicine. No C5-DMB-ceramide was
identified within the chlamydial inclusion membrane or within
the chlamydial inclusion.
DISCUSSION
Concerning the role of the cytoskeleton in chlamydial de-
velopment subsequent to internalization, we devoted our at-
tention early to the aggregation and fusion of chlamydiae-
containing vesicles and later to inclusion formation and
maturation into one vesicle. The findings reported here indi-
cate a clear difference in the utilization of the host cell cy-
toskeleton by the more invasive LGV biovar than by the genital
C. trachomatis biovar (Table 1). In LGV-infected cells, both
MF and MT disruption interfered with the fusion of multiple
EB-containing vesicles to form one large mature inclusion. The
ability of serovar L2 to infect cells lacking an intact cytoskel-
eton, however, was not affected. In serovar E-infected cells,
MF and MT disruption did not affect vesicle aggregation or
inclusion formation. However, a dose-dependent decrease in
the percentage of cells infected by serovar E was seen in cells
lacking intact MF. This finding suggests that serovar E requires
an intact MF network for the efficient infection of host cells.
From these results, we do not know whether serovar E utilizes
MF for entry into host cells and/or for vesicle aggregation and
fusion immediately after entry. Serovar E-containing vesicles
may require aggregation and fusion directly after entry in order
to survive within the host cell. If this is a MF-dependent pro-
cess, it would explain the low percentage of CD-exposed cells
that were infected by serovar E.
The need for MF in chlamydial entry is more understand-
able for host cells grown in vitro, since eukaryotic cells have
been shown to pick up EB as they migrate across the substra-
tum (9). In vivo, the naturally polarized cells of the genital
epithelial mucosae are presumably less motile. The nonmotile,
metabolically inert EB bind initially to the tips of microvilli en
route to the cell surface, where they are seen to enter into
coated pits at the base of microvilli (21, 22, 62). Disruption of
the MF in these microvilli may decrease serovar E infectivity.
Alternatively, the host cell receptor to which serovar E binds
may require MF to move to clathrin-coated pits in the apical
membrane prior to endocytosis.
The capability of serovar L2 to infect cells without an intact
cytoskeleton suggests that this pathogen binds to a receptor
FIG. 5. Disruption of MF with CD delays C. trachomatis serovar L2 inclusion
fusion and leads to multiple inclusions per cell. HEC-1B (A) and McCoy (B)
cells were infected with serovar L2 after a 1-h incubation with DMSO (1:125) or
CD at various concentrations. Inclusions were stained with Syva at 24 h p.i., and
the number of inclusions per cell was determined and averaged for each coverslip
examined. Values are means 6 standard errors of the means from three exper-
iments.
328 SCHRAMM AND WYRICK INFECT. IMMUN.
that does not associate with the host cell cytoskeleton for
uptake. Serovar L2 may utilize a ubiquitous cell surface recep-
tor which is endocytosed via an MF-independent pathway be-
sides that involving clathrin. It has recently been reported that
molecules endocytosed without clathrin are delivered to the
same endocytic compartment as the transferrin receptor which
is internalized through clathrin-coated pits (19). Therefore,
serovar L2 may enter target cells by several pathways, from
both apical and basolateral surfaces, and still congregate in a
common endosomal vesicle.
The various routes of uptake and development of the two
serovars into host cells may reflect inherent differences in their
in vivo sequelae. Serovar E is a noninvasive pathogen which
presumably enters and exits from the apical surface of host
cells, while serovar L2 invades tissue underlying the epithelium
and may enter and exit through both the apical and basolateral
surfaces. From these data, we have devised a model for the
modes of C. trachomatis serovar E and L2 infection and spread
in an epithelial monolayer (Fig. 9). We hypothesize that sero-
var L2 enters host cells from both the apical and basolateral
surfaces without the help of the cytoskeleton. After entry,
serovar L2-containing vesicles utilize MF and MT to aggregate
and fuse to form one mature inclusion. Upon maturation, the
serovar L2 inclusion may transport along MT to the basolateral
domain, where it leaves the host cell to infect cells under the
epithelial layer. Our model of serovar E infection starts with
entry at the apical surface with the help of MF. Serovar E-con-
taining vesicles then aggregate and fuse without the use of the
cytoskeleton. Because of this lack of association with MT, the
mature serovar E inclusion remains in the apical domain,
where it eventually escapes from the host cell to infect the
apical surfaces of neighboring cells.
It has been proposed that the MT network functions as an
anchoring point for the attachment of actin filaments (49). If
MF integrity depends upon the MT network, MT disruption
would lead to MF disruption. If this is so, serovar L2 may
require only MF for inclusion fusion and MT disruption may
indirectly lead to the formation of multiple inclusions per cell.
Several reports have suggested that vesicles and organelles
move bidirectionally on MT, detach, and then move along MF
in a slow and unidirectional manner (28, 61). Also, in coelo-
mocytes, the orientation of MF-dependent cortical flow has
been shown to be MT dependent (10). From our results, we
cannot determine whether serovar L2-containing vesicles di-
rectly use MT for inclusion fusion. Our examination of col-
chicine-exposed cells did not reveal any damage to MF. At the
level of fluorescence microscopy, however, it may not be pos-
FIG. 6. MT depolymerization delays the formation of one C. trachomatis serovar L2 inclusion per cell until later times in the developmental cycle. HEC-1B cells
infected with serovar L2 were untreated (A and D) or treated with 10 mM colchicine (B and E) or 33 mM nocodazole (C and F). Serovar L2 inclusions were stained
with Syva at 24 (A to C) or 44 (D to F) h p.i.
FIG. 7. Transmission electron microscopy reveals multiple C. trachomatis
serovar L2 inclusions in polarized HEC-1B cells lacking polymerized MT.
HEC-1B cells were untreated (A) or preexposed to 10 mM colchicine (B),
infected with serovar L2, and processed for Epon-Araldite embedding at 24 h p.i.
Bar 5 1.7 mm.
FIG. 8. The chlamydial inclusion and inclusion membrane do not contain
sphingolipids of the trans-Golgi. The Golgi apparatus was stained with BODIPY
FL C5-DMB-ceramide in host cells infected with C. trachomatis serovar L2.
HEC-1B (A to C) or McCoy (D to F) cells were fixed and stained 24 h p.i.
Chlamydial inclusions (arrowhead) were examined with phase microscopy (A
and D) and fluorescence microscopy using fluorescein filters (B and E) or
rhodamine filters (C and F).
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sible to detect subtle changes in the arrangement of the cy-
toskeleton.
In an attempt to show directly that serovar L2 inclusions
traffic along MT, we labeled chlamydiae and MT with two
distinct fluorescent antibodies within HEC-1B cells. Although
we could identify inclusions in close proximity to MT, we could
not determine if there was direct contact between the two
structures at the level of fluorescence microscopy (data not
shown). Future studies using high-voltage transmission elec-
tron microscopy (7) to examine the possible interaction of
inclusions and MT within infected cells will help to more
clearly define the mechanisms involved in chlamydial inclusion
development.
The disruption of polymerized MF or MT, within cells in-
fected with C. trachomatis serovar L2, inhibits inclusion fusion
only early in the developmental cycle. Nocodazole removal at
4 h p.i. did not affect serovar L2 inclusion development, but its
addition, as late as 12 h p.i. to infected HEC-1B cells, resulted
in multiple inclusions per cell. This finding suggests that MT
play a role in serovar L2 inclusion fusion a few hours after
entry and through the first half of the developmental cycle.
Late in the developmental cycle, chlamydial inclusions may
grow large enough to collide randomly in the cytoplasm and
can then fuse without the help of microtubules. Vesicle traf-
ficking along MT is thought to be required for large distances
within the cell, as in the movement of endosomes to lysosomes,
and not for short movements, as from the endoplasmic retic-
ulum to the Golgi (25). This would explain why serovar L2-
containing endosomes require MT for aggregation early after
entry but do not need them once the inclusions are large
enough to be in close proximity.
It is clear that MT-depolymerizing drugs disrupt the struc-
ture of the Golgi, but it is unclear whether Golgi functions are
affected. Several studies have shown that MT disruption causes
a decrease in the rate of glycoprotein transport and secretion
to the plasma membrane but does not affect glycoprotein syn-
thesis and, hence, Golgi function (2, 3, 56). Other studies have
shown that MT disruption has no effect on glycoprotein syn-
thesis or transport to the cell surface (15, 54) but that the
polarized expression of transported Golgi products is inhibited
(45, 48). We localized Golgi vesicles within HEC-1B cells in-
fected with chlamydiae. Golgi vesicles were found surrounding
the inclusion but not incorporated into the inclusion mem-
brane in amounts that we could detect by fluorescence micros-
copy. Because of technical limitations, however, we cannot rule
out the possibility that Golgi vesicles are transported to and
fuse with the growing inclusion to supply nutrients and mem-
brane and that MT disruption inhibits this pathway, leading to
a decrease in inclusion fusion. The appearance of Golgi vesi-
cles ringing the inclusion may imply a need for Golgi compo-
nents during chlamydial growth or may simply be the result of
the growing inclusion pushing against cellular organelles in the
nuclear hof.
Previously reported findings on the use of the host cell cy-
toskeleton by chlamydiae differ from those presented here.
There are several parameters that differ between these exam-
inations which may explain the discrepancies. (i) Experiments
of chlamydial infection have been performed in many different
cell lines. Not all cell types have the same amounts and distri-
butions of filamentous actin. MT dynamics (52) and arrange-
ment (58) have also been shown to be cell type specific. MT in
the lamellae of epithelial cells are less dynamic than the ma-
jority found in fibroblasts because of a reduced rate of growth
and depolymerization. Therefore, MT- and MF-disrupting
drugs will affect various cells in different ways. (ii) The mode of
chlamydial inoculation onto host monolayers affects the path-
way of uptake. Centrifugation favors phagocytosis, while ad-
sorption leads to pinocytic entry (43, 44). (iii) Drugs used to
disrupt the cytoskeleton have different mechanisms of action.
Vinblastine and vincristine disrupt the structure of preformed
MT, giving rise to paracrystalline arrays (39), whereas colchi-
cine alters the dynamic equilibrium between monomeric and
polymeric tubulin (34). Several investigations of chlamydial
entry into cells exposed to cytochalasin B did not find an
FIG. 9. A model for C. trachomatis infection of polarized epithelial cells.
Serovar E utilizes MF during entry (1), fuses inclusions without the use of the
host cell cytoskeleton (2), and is released from the apical surface (3), which
allows rapid infection of the apical surfaces of neighboring cells. C. trachomatis
serovar L2 enters cells without the use of the cytoskeleton (4) but utilizes MF and
possibly MT for inclusion fusion (5). Mature serovar L2 EB are released from the
basolateral cell surface to invade underlying tissues (6) and may then enter
through basolateral as well as apical membranes of host cells.
TABLE 1. Effect of host cell cytoskeletal disruption on C. trachomatis inclusion development
Serovar Host cell
Inclusion morphology
MT disruption MF disruption
Earlya Mid Late Early Mid Late
E HEC-1B Normalb Normal Normal Normal Normalc Normalc
McCoy Normal Normal Normal Less aggregatedd Normalc Normalc
L2 HEC-1B Less aggregated Multiplee Normal Normal Multiple Normal
McCoy Less aggregated Multiple Normal Less aggregated Multiple Normal
a Stage of developmental cycle.
b Chlamydial inclusions fused to form one large vesicle.
c Inclusion morphology was normal but there was a decrease in the number of infected cells.
d Endosomes containing chlamydiae were more dispersed in the host cell cytoplasm than in untreated, infected cells.
e Contained more than one inclusion per cell.
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inhibition in infection. This may be explained by a study which
revealed that cytochalasin B does not sever MF at the cell
periphery as does CD (10). DMSO, at 5%, depolymerizes class
I actin filaments at the plasma membrane (40, 61), and CD is
routinely dissolved in DMSO. We did find a slight decrease in
the infectivity of DMSO-exposed cells by serovar E (Fig. 1).
(iv) Finally, temperature affects cell structure. MT are known
to depolymerize at 48C (61), and several investigators inoculate
chlamydiae onto host cells at reduced temperatures.
The results from these experiments show that (i) C. tracho-
matis serovars E and L2 utilize different pathways of infection,
(ii) the cytoskeleton plays a unique role in the infection of host
cells by serovars E and L2, and (iii) the differences are consis-
tent in both epithelial cells and fibroblasts. Further investiga-
tion of the involvement of the chlamydial inclusion with the
host cell cytoskeleton is needed to understand the intracellular
survival of this complex pathogen.
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